Changing CLL Treatment Landscape: Updates From an Expert

Published on

Topics include: Treatments

What new therapies are in the pipeline for chronic lymphocytic leukemia (CLL)? What is the side effect profile for novel agents? CLL specialist and dedicated researcher Dr. Nicole Lamanna, from Columbia University Medical Center, shares insight on the latest treatment developments and progress in clinical trials. With a hopeful outlook, Dr. Lamanna describes new therapies under investigation, recent drug approvals and how to sequence novel agents to reduce toxicities. Watch now to hear expert updates on CLL therapy.

This program is sponsored by AbbVie, Inc, Genentech, Inc and Adaptive Biotechnologies. These organizations have no editorial control. It is produced by Patient Power in partnership with The Leukemia & Lymphoma Society (LLS), CLL Society and OHC (Oncology Hematology Care). Patient Power is solely responsible for program content.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

 

View more programs featuring and

Produced in association with , and

Related Programs

Morning Session: Accessing State-of-the-Art CLL Care

In this morning session, CLL experts break down the latest treatment research and access to the best care. Watch as they share their expert knowledge.

Published:

Are Community Oncologists Informed About Nuances in CLL Care?

Are community oncologists informed on the ever-changing CLL treatment landscape? Listen as expert Dr. William Wierda explains how patients can find the best approach to manage their CLL.

Published:

Clinical Trial Updates on CLL Patients With Genetic Mutations

What implications does mutational status have for frontline treatment of CLL? Watch as CLL expert Dr. Jeff Sharman discusses recent studies on the correct management of frontline CLL treatment.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 20, 2019